As far as a purported reason for today's stock act
Post# of 72447
(Total Views: 651)
Posted On: 08/10/2021 5:00:38 PM
As far as a purported reason for today's stock action, I have been informed (but did not verify myself) that minions allegedly of a certain "fiery" enemy of IPIX have been claiming untruthfully to have advance information that the clinical trials failed. (Note that I say this is UNTRUE.)
Although the outcome will NOT be the same for IPIX, this is EXACTLY the same tactic that he used in the past. Some years ago, ONTY, another target of the "empty offices" BS from Mako and just undoubtedly utterly coincidentally also HQ'ed in the Boston area, had a crucial clinical trial about to conclude. "Someone" tweeted that he had advance information that the clinical trial had failed. Investors sold the stock off. Then, 3 days later, the company announced their results -- which were great.
However, THAT company, unlike IPIX, had taken on a huge load of debt. They needed to sell stock or get a partner to survive. But, all the bamboozled investors did NOT buy their stock back and the stock price stayed at the depressed level. ONTY had the choice of selling itself for a lowball price or going bankrupt, so it sold itself. Most of the investors lost money, on a stock with a hugely successful clinical trial but whose stock was murdered before the results came out.
Over a dozen of us reported that tweeting individual to the SEC, which declined to investigate. I guess they were too busy investigating people like Martha Stewart for her $70k stock sale, instead of spending time on a case of alleged stock manipulation, with evidence including screen shots of someone untruthfully bragging about having non-public information.
Again, let me emphasize that IPIX IS NOT IN THE BAD POSITION ONTY WAS IN. They had had a CEO who took on immense debt and toxic financing. IPIX can't be forced into liquidation like poor ONTY.
But, this is the method. Spread a lie, get jumpy shareholders to sell, and then, if the clinical trial results are good, well, they were able to get rid of some shareholders who won't buy in again.
And who knows? Maybe some of the members of the traders' gangs used today as an opportunity to cover part of their short position.
Although the outcome will NOT be the same for IPIX, this is EXACTLY the same tactic that he used in the past. Some years ago, ONTY, another target of the "empty offices" BS from Mako and just undoubtedly utterly coincidentally also HQ'ed in the Boston area, had a crucial clinical trial about to conclude. "Someone" tweeted that he had advance information that the clinical trial had failed. Investors sold the stock off. Then, 3 days later, the company announced their results -- which were great.
However, THAT company, unlike IPIX, had taken on a huge load of debt. They needed to sell stock or get a partner to survive. But, all the bamboozled investors did NOT buy their stock back and the stock price stayed at the depressed level. ONTY had the choice of selling itself for a lowball price or going bankrupt, so it sold itself. Most of the investors lost money, on a stock with a hugely successful clinical trial but whose stock was murdered before the results came out.
Over a dozen of us reported that tweeting individual to the SEC, which declined to investigate. I guess they were too busy investigating people like Martha Stewart for her $70k stock sale, instead of spending time on a case of alleged stock manipulation, with evidence including screen shots of someone untruthfully bragging about having non-public information.
Again, let me emphasize that IPIX IS NOT IN THE BAD POSITION ONTY WAS IN. They had had a CEO who took on immense debt and toxic financing. IPIX can't be forced into liquidation like poor ONTY.
But, this is the method. Spread a lie, get jumpy shareholders to sell, and then, if the clinical trial results are good, well, they were able to get rid of some shareholders who won't buy in again.
And who knows? Maybe some of the members of the traders' gangs used today as an opportunity to cover part of their short position.
(11)
(0)